Oncothyreon presents positive data
June 01, 2015 at 13:55 PM EDT
Oncothyreon
Inc. (Nasdaq: ONTY) presented positive data from several ongoing trials
of ONT-380 in treating breast cancer. Shares of the biopharmaceutical
gained 89 cents to $4.31.
